Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Alzheimer's Disease

Free Subscription Articles published in Neurochem Res Retrieve available abstracts of 57 articles: HTML format

Single Articles

October 2025
1. YANG T
   Molecular Mechanisms of EDC-Induced Alzheimer's Disease and of Traditional Chinese Medicine Active Substances in Treating AD and Antagonizing EDC-Induced Effects.
   Neurochem Res. 2025;50:319.
   PubMed     Abstract available
   
   
   September 2025
2. TALIB M, Siddiqui N, Tripathi PN, Chaudhary A, et al
   Correction to: Ameliorative Role of Phosphodiesterase-5 (PDE-5) Inhibitor "Avanafil" Via Modulating cAMP & cGMP Pathway Against Alzheimer's Disease.
   Neurochem Res. 2025;50:289.
   PubMed    
   
   
   August 2025
3. WANG S, Xu Z, Wang S, Peng Q, et al
   Alamandine Rescues Cognitive Impairment and Ameliorates Alzheimer's Disease-Like Neuropathology in APP/PS1 Mice.
   Neurochem Res. 2025;50:277.
   PubMed     Abstract available
   
   
   
4. PARMAR P, Chauhan H, Modi P, Israni D, et al
   Pharmacological Evaluation and In-Silico Study of Sabinene as a Potential Anti-Alzheimer's Drug in AlCl(3)-Induced Rat Model via BACE-1 and GSK3beta Modulation.
   Neurochem Res. 2025;50:278.
   PubMed     Abstract available
   
   
   
5. WANG XC, Wu GL, Cai HY, Chu CL, et al
   Jiao-Tai-Wan Improves Cognitive Impairment by Regulating Nrf2/ARE/HO-1 Signaling Pathway in APP/PS1 Mice.
   Neurochem Res. 2025;50:268.
   PubMed     Abstract available
   
   
   
6. TALIB M, Siddiqui N, Tripathi PN, Chaudhary A, et al
   Ameliorative Role of Phosphodiesterase-5 (PDE-5) Inhibitor "Avanafil" via Modulating cAMP & cGMP Pathway Against Alzheimer's Disease.
   Neurochem Res. 2025;50:258.
   PubMed     Abstract available
   
   
   July 2025
7. YU Q, Li L, Yu S, Han J, et al
   Mitochondrial Damage and Autophagy Dysregulation in Alzheimer's Disease: Mechanisms and Therapeutic Opportunities.
   Neurochem Res. 2025;50:251.
   PubMed     Abstract available
   
   
   
8. AMIN SS, Qusti S, Al-Otaibi WA, AlMotwaa SM, et al
   Correction: The Neuroprotective Impact of Agomelatine in Preserving Brain Tissue Molecular Structure Against Alzheimer's Disease Etiology.
   Neurochem Res. 2025;50:246.
   PubMed    
   
   
   June 2025
9. YE K, Zeng M, Zhang B, Hao F, et al
   Piper Kadsura Extract and its Bioactive Components Attenuates Abeta(25-35)-Induced Neurotoxicity by Modulating Glycolysis and Activating the SIRT1/PPARgamma/GLUT1 Axis.
   Neurochem Res. 2025;50:216.
   PubMed     Abstract available
   
   
   
10. BAVAFA A, Meftahi GH, Pirzad Jahromi G
    Multidimensional Evaluation of the Streptozotocin-Induced Alzheimer's Model: Integrating Molecular, Histopathological, and Behavioral Correlates Over Time.
    Neurochem Res. 2025;50:214.
    PubMed     Abstract available
    
    
    
11. QADIR H, Hussain SH, Ghaffar A, Shah FA, et al
    Targeting Fyn Kinase for Alleviation of Cognitive Impairment in Streptozocin-Induced Alzheimer's Disease in Mice by Loperamide; An Experimental and in Silico Analysis.
    Neurochem Res. 2025;50:212.
    PubMed    
    
    
    
12. JUSTO AFO, Toscano ECB, Goncalves NG, Leite REP, et al
    Selective Vulnerability of Hippocampi for Nitric Oxide Synthases in Alzheimer's Disease Pathology and Cognitive Abilities.
    Neurochem Res. 2025;50:197.
    PubMed     Abstract available
    
    
    
13. SHAJI V, Amrutha S, Pervaje R, Abhinand CS, et al
    Exploration of Asparagus racemosus Willd for Alzheimer's Disease Through Integrated Metabolomics and Network Pharmacology Analyses Targeting BACE1 Protein.
    Neurochem Res. 2025;50:190.
    PubMed     Abstract available
    
    
    
14. AMIN S, Qusti S, Al-Otaibi WA, AlMotwaa SM, et al
    The Neuroprotective Impact of Agomelatine in Preserving Brain Tissue Molecular Structure Against Alzheimer's Disease Etiology.
    Neurochem Res. 2025;50:189.
    PubMed     Abstract available
    
    
    
15. ZHOU Y, Diwu YC, Li YX, Zhang JY, et al
    Neuroprotective Effects of Tectoridin in H(2)O(2)-Induced Oxidative Stress and an Amyloid-Infused Rat Model of Alzheimer's Disease.
    Neurochem Res. 2025;50:179.
    PubMed     Abstract available
    
    
    May 2025
16. LV X, Ye T, Yang W, Zhu Z, et al
    Weissella confusa Attenuates Cognitive Deficits in Alzheimer's Disease by Reducing Oxidative Stress Via the SIRT1/PGC-1alpha Signaling Pathway.
    Neurochem Res. 2025;50:175.
    PubMed     Abstract available
    
    
    
17. KAUR A, Goel RK
    Modelling Epilepsy Associated Alzheimer's Disease Through Mitochondrial Complex-I Inhibition: Neurochemical and Therapeutic Perspectives.
    Neurochem Res. 2025;50:163.
    PubMed     Abstract available
    
    
    
18. SUN YW, Lei XY, Lyu XY, Yin Y, et al
    Decoupling of Neurochemical and White Matter Microstructural Integrity in Posterior Cingulate Cortex Predicts Early Alzheimer's Disease Progression.
    Neurochem Res. 2025;50:159.
    PubMed     Abstract available
    
    
    
19. HU Y, Liu Y, Zhu Q, Chen Y, et al
    Identification of Novel Biomarkers Related to Vesicle Trafficking in Alzheimer's Disease Using Bioinformatics Approaches.
    Neurochem Res. 2025;50:157.
    PubMed     Abstract available
    
    
    April 2025
20. CHENG L, Meng X, Tian D, Zheng B, et al
    Targeting UAF1 Alleviate Neurotoxicity by Inhibiting APP/NLRP3 Axis-Mediated Pyroptosis and Apoptosis.
    Neurochem Res. 2025;50:135.
    PubMed     Abstract available
    
    
    March 2025
21. CAO F, Zhang P, Chi Y, Wang Y, et al
    Celastrol Ameliorated Alzheimer's Disease in Mice by Enhancing TBX21/TREM2 Expression in Microglia and Inhibiting Tau Phosphorylation.
    Neurochem Res. 2025;50:126.
    PubMed     Abstract available
    
    
    
22. ORDONEZ WOC, Palomino NV, Varela PEV, Martinez IB, et al
    Alkaloids from Caliphruria subedentata (Amaryllidaceae) as Regulators of AChE, BuChE, NMDA and GSK3 Activity: An In Vitro and In Silico Approach for Mimicking Alzheimer s Disease.
    Neurochem Res. 2025;50:116.
    PubMed     Abstract available
    
    
    February 2025
23. WANG J, Meng X, Yang J, Tang Y, et al
    Improvements in Exercise for Alzheimer's Disease: Highlighting FGF21-Induced Cerebrovascular Protection.
    Neurochem Res. 2025;50:95.
    PubMed     Abstract available
    
    
    January 2025
24. ATHARI SZ, Kazmi S, Vatandoust SM, Mahmoudi J, et al
    Varenicline Attenuates Memory Impairment in Amyloid-Beta-Induced Rat Model of Alzheimer's Disease.
    Neurochem Res. 2025;50:86.
    PubMed     Abstract available
    
    
    
25. DA COSTA P, Schetinger MRC, Baldissarelli J, Reichert KP, et al
    Blackcurrant (Ribes nigrum L.) and Its Association with Donepezil Restore Cognitive Impairment, Suppress Oxidative Stress and Pro-inflammatory Responses, and Improve Purinergic Signaling in a Scopolamine-Induced Amnesia Model in Mice.
    Neurochem Res. 2025;50:79.
    PubMed     Abstract available
    
    
    
26. LIU X, Lv Z, Huang Q, Lei Y, et al
    The Role of Oligodendrocyte Lineage Cells in the Pathogenesis of Alzheimer's Disease.
    Neurochem Res. 2025;50:72.
    PubMed     Abstract available
    
    
    December 2024
27. SMAIL SW
    Targeting Neuroinflammation and Apoptosis: Cardamonin's Cognitive Benefits in Alzheimer's 5XFAD Mice.
    Neurochem Res. 2024;50:57.
    PubMed     Abstract available
    
    
    
28. PASHAEI S, Shabani S, Mohammadi S, Morozova-Roche LA, et al
    Differential Expression of Neurodegeneration-Related Genes in SH-SY5Y Neuroblastoma Cells Under the Influence of Cyclophilin A: Could the Enzyme be a Likely Trigger and Therapeutic Target for Alzheimer's Disease?
    Neurochem Res. 2024;50:47.
    PubMed     Abstract available
    
    
    November 2024
29. ARORA Y, Samkaria A, Maroon JC, Mandal PK, et al
    Longitudinal Monitoring of Glutathione Stability in Different Microenvironments.
    Neurochem Res. 2024;50:9.
    PubMed     Abstract available
    
    
    August 2024
30. THENMOZHI AJ, Raja TRW, Janakiraman U, Manivasagam T, et al
    Retraction Note: Neuroprotective Effect of Hesperidin on Aluminium Chloride Induced Alzheimer's Disease in Wistar Rats.
    Neurochem Res. 2024 Aug 23. doi: 10.1007/s11064-024-04232.
    PubMed    
    
    
    
31. COLIN-MARTINEZ E, Espino-de-la-Fuente C, Arias C
    Age- and Sex-Associated Wnt Signaling Dysregulation is Exacerbated from the Early Stages of Neuropathology in an Alzheimer's Disease Model.
    Neurochem Res. 2024 Aug 21. doi: 10.1007/s11064-024-04224.
    PubMed     Abstract available
    
    
    July 2024
32. ASCHNER M, Skalny AV, Santamaria A, Rocha JBT, et al
    Epigenetic Mechanisms of Aluminum-Induced Neurotoxicity and Alzheimer's Disease: A Focus on Non-Coding RNAs.
    Neurochem Res. 2024 Jul 27. doi: 10.1007/s11064-024-04214.
    PubMed     Abstract available
    
    
    
33. LI C, Zhao X, Xu H, Liu X, et al
    NMN Synbiotics: A Multifaceted Therapeutic Approach for Alzheimer's Disease.
    Neurochem Res. 2024 Jul 22. doi: 10.1007/s11064-024-04210.
    PubMed     Abstract available
    
    
    
34. LUO JS, Zhai WH, Ding LL, Zhang XJ, et al
    MAMs and Mitochondrial Quality Control: Overview and Their Role in Alzheimer's Disease.
    Neurochem Res. 2024 Jul 13. doi: 10.1007/s11064-024-04205.
    PubMed     Abstract available
    
    
    
35. LOPEZ HANOTTE J, Peralta F, Reggiani PC, Zappa Villar MF, et al
    Investigating the Impact of Intracerebroventricular Streptozotocin on Female Rats with and without Ovaries: Implications for Alzheimer's Disease.
    Neurochem Res. 2024 Jul 10. doi: 10.1007/s11064-024-04204.
    PubMed     Abstract available
    
    
    
36. GAYGER-DIAS V, Menezes L, Da Silva VF, Stiborski A, et al
    Changes in Astroglial Water Flow in the Pre-amyloid Phase of the STZ Model of AD Dementia.
    Neurochem Res. 2024;49:1851-1862.
    PubMed     Abstract available
    
    
    June 2024
37. OLIVEIRA-LIMA OC, de Carvalho GA, do Prado Assuncao L, Bailao AM, et al
    GlyT1 Inhibition by NFPS Promotes Neuroprotection in Amyloid-beta-Induced Alzheimer's Disease Animal Model.
    Neurochem Res. 2024 Jun 18. doi: 10.1007/s11064-024-04190.
    PubMed     Abstract available
    
    
    
38. SHENG L, Bhalla R
    Biomarkers and Target-Specific Small-Molecule Drugs in Alzheimer's Diagnostic and Therapeutic Research: From Amyloidosis to Tauopathy.
    Neurochem Res. 2024 Jun 6. doi: 10.1007/s11064-024-04178.
    PubMed     Abstract available
    
    
    
39. WANG XF, Xiang XH, Wei J, Zhang PB, et al
    Raddeanin A Protects the BRB Through Inhibiting Inflammation and Apoptosis in the Retina of Alzheimer's Disease.
    Neurochem Res. 2024 Jun 4. doi: 10.1007/s11064-024-04145.
    PubMed     Abstract available
    
    
    May 2024
40. QIU NZ, Hou HM, Guo TY, Lv YL, et al
    Phosphodiesterase 8 (PDE8): Distribution and Cellular Expression and Association with Alzheimer's Disease.
    Neurochem Res. 2024 May 23. doi: 10.1007/s11064-024-04156.
    PubMed     Abstract available
    
    
    
41. KUEDO Z, Binlateh T, Benjakul S, Hutamekalin P, et al
    Pretreatment with Liposome-Encapsulated Shrimp Shell Extract Attenuated Neuronal Damage and Death in Abeta(1-42)-Induced Memory Deficits in Rats.
    Neurochem Res. 2024;49:1166-1187.
    PubMed     Abstract available
    
    
    March 2024
42. XIAO X, Rui Y, Jin Y, Chen M, et al
    Relationship of Sleep Disorder with Neurodegenerative and Psychiatric Diseases: An Updated Review.
    Neurochem Res. 2024;49:568-582.
    PubMed     Abstract available
    
    
    February 2024
43. ZHANG LJ, Zhang HZ, Liu YW, Tang M, et al
    Sulphated Fucooligosaccharide from Sargassum Horneri: Structural Analysis and Anti-Alzheimer Activity.
    Neurochem Res. 2024 Feb 2. doi: 10.1007/s11064-024-04107.
    PubMed     Abstract available
    
    
    
44. ALLNUTT MA, Matera KM
    Stabilization and Reduced Cytotoxicity of Amyloid Beta Aggregates in the Presence of Catechol Neurotransmitters.
    Neurochem Res. 2024;49:379-387.
    PubMed     Abstract available
    
    
    
45. DHALIWAL N, Dhaliwal J, Chopra K
    7, 8-dihydroxyflavone Ameliorates Cholinergic Dysfunction, Inflammation, Oxidative Stress, and Apoptosis in a Rat Model of Vascular Dementia.
    Neurochem Res. 2024 Feb 1. doi: 10.1007/s11064-023-04090.
    PubMed     Abstract available
    
    
    January 2024
46. LIU Y, Meng XK, Shao WZ, Liu YQ, et al
    miR-34a/TAN1/CREB Axis Engages in Alleviating Oligodendrocyte Trophic Factor-Induced Myelin Repair Function and Astrocyte-Dependent Neuroinflammation in the Early Stages of Alzheimer's Disease: The Anti-Neurodegenerative Effect of Treadmill Exercise.
    Neurochem Res. 2024 Jan 30. doi: 10.1007/s11064-024-04108.
    PubMed     Abstract available
    
    
    
47. TAKANO-KAWABE K, Matoba K, Nakamura Y, Moriyama M, et al
    Low Density Lipoprotein Receptor-related Protein 2 Expression and Function in Cultured Astrocytes and Microglia.
    Neurochem Res. 2024;49:199-211.
    PubMed     Abstract available
    
    
    
48. NADERI S, Motamedi F, Pourbadie HG, Rafiei S, et al
    Neuroprotective Effects of Ferrostatin and Necrostatin Against Entorhinal Amyloidopathy-Induced Electrophysiological Alterations Mediated by voltage-gated Ca(2+) Channels in the Dentate Gyrus Granular Cells.
    Neurochem Res. 2024;49:99-116.
    PubMed     Abstract available
    
    
    November 2023
49. ZHAN Q, Kong F, Shao S, Zhang B, et al
    Pathogenesis of Depression in Alzheimer's Disease.
    Neurochem Res. 2023 Nov 28. doi: 10.1007/s11064-023-04061.
    PubMed     Abstract available
    
    
    October 2023
50. SASIDHARAN R, Mohanan R, Kukreti N, Raj P, et al
    MAO-B Inhibitor (2E)-3-(4-Bromophenyl)-1-(1H-indol-3-yl) prop-2-en-1-one as a Neuroprotective Agent Against Alzheimer's Disease.
    Neurochem Res. 2023 Oct 9. doi: 10.1007/s11064-023-04031.
    PubMed     Abstract available
    
    
    September 2023
51. WU Z, Tang W, Ibrahim FEEM, Chen X, et al
    Abeta Induces Neuroinflammation and Microglial M1 Polarization via cGAS-STING-IFITM3 Signaling Pathway in BV-2 Cells.
    Neurochem Res. 2023;48:2881-2894.
    PubMed     Abstract available
    
    
    
52. ASGHAR H, Ahmed T
    Comparative Study of Time-Dependent Aluminum Exposure and Post-Exposure Recovery Shows Better Improvement in Synaptic Changes and Neuronal Pathology in Rat Brain After Short-Term Exposure.
    Neurochem Res. 2023;48:2731-2753.
    PubMed     Abstract available
    
    
    August 2023
53. PANG LW, Hamzah S, Tan SLJ, Mah SH, et al
    The Effects and Mechanisms of Xanthones in Alzheimer's Disease: A Systematic Review.
    Neurochem Res. 2023 Aug 14. doi: 10.1007/s11064-023-04005.
    PubMed     Abstract available
    
    
    May 2023
54. ZHOU Y, Wang Y, Wang Y, Chen L, et al
    LncRNA NKILA Exacerbates Alzheimer's Disease Progression by Regulating the FOXA1-Mediated Transcription of TNFAIP1.
    Neurochem Res. 2023 May 23. doi: 10.1007/s11064-023-03944.
    PubMed     Abstract available
    
    
    April 2023
55. SIDDIQUI N, Ali J, Parvez S, Najmi AK, et al
    Neuroprotective Role of DPP-4 Inhibitor Linagliptin Against Neurodegeneration, Neuronal Insulin Resistance and Neuroinflammation Induced by Intracerebroventricular Streptozotocin in Rat Model of Alzheimer's Disease.
    Neurochem Res. 2023 Apr 20. doi: 10.1007/s11064-023-03924.
    PubMed     Abstract available
    
    
    
56. LIM D, Tapella L, Dematteis G, Talmon M, et al
    Calcineurin Signalling in Astrocytes: From Pathology to Physiology and Control of Neuronal Functions.
    Neurochem Res. 2023;48:1077-1090.
    PubMed     Abstract available
    
    
    
57. HUFFELS CFM, Middeldorp J, Hol EM
    Ass Pathology and Neuron-Glia Interactions: A Synaptocentric View.
    Neurochem Res. 2023;48:1026-1046.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Alzheimer's Disease is free of charge.